Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies.

    If you have registered with Prism in the past, please call Dayna 651-724-5047 to update your profile or learn about available studies. 

    We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

     

    Unfortunately at this time, Prism can not allow volunteers who live over 200 miles away to participate in research studies. If you live out of state or over 200 miles away please call Geoff at 651-641-2911 with questions. 

  • Refer Your Friends & Family to Participate

    Simply help us get the word out about Prism Clinical Research and we’ll give you $100 for every friend you refer that completes a study.

    It’s that easy! Make money with each referral, and there’s no limit to how many friends you can refer!

    Rules:

    • Subject must complete the study.
    • Subject may not be referred more than one time.
    • Subjects may not refer each other.
    • Subject must complete the study before payment can be received.
    • Subjects eligible for Referral: (1) Must not be in Prism Clinical Research database; (2) Must not have participated in any study at Prism.
    • In the event that a subject is referred by multiple people, the first person who referred will receive payment.
    • Eligibility will be determined by Prism. Prism reserves the right to revise or eliminate this program at any time without notice.

     

     

  • Diagnosed with Liver Impairment?

    Prism Research has upcoming studies for individuals diagnosed with liver impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of liver impairment when compared to volunteers with normal liver function.

     If you or someone you know has been diagnosed with liver impairment and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Currently, we do not have any studies available for those diagnosed with liver impairment. We hope to start a study in the near future. 

    Contact Dayna 651-724-5047 or daynas@prismresearchinc.com

  • **Freelancers Wanted**

    Freelancers, participate in a research study at Prism Research and earn extra income while completing your freelance projects in our comfortable facility by participating in one of our many research studies. If you're 18 - 60, healthy and have a flexible schedule, Prism Research has several current and upcoming FDA Approved Studies for you to consider. 

    Participants will receive health examinations and blood tests at no charge, meals and compensation ranging from $900 to $3,500 (or more) for study participation time. 

    Call for more information if you:
    � Currently Live in Minnesota or Western Wisconsin
    � Have Flexibility To Work Remotely
    � Want to Earn Extra Income

    *Interested in learning more about what clinical research studies are available? Reply or call Lindsay, Recruitment Coordinator at (651) 368-3360.

    Located in St. Paul

  • Study 1710 Part 1: Individuals with Moderate Renal Impairment

    Research Purpose: To determine whether the investigational drug displays the clinical safety profile to support further development in patients with moderately impaired renal function.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women of non-childbearing potential are allowed to participate

    Age

    40-85 years of age

    Body Mass Index (BMI)

    Between 18-40 kg/m²

    Minimum Weight

    50 kg

    MDRD

    30-59 mL/min/1.73 m²

    Angiotensin receptor blocker (ARB)

    Must be on an ARB for at last a month prior to screening

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 11 weeks. 

    Clinic Stay

    • Participants will be confined at Prism Clinical Research one time during the study period for up to 16 days and (15 nights).

    Return Clinic Visits

    • There is one return clinic visit approximately 1 week after discharge.

     

    Phone Call

    • There is one Phone call approximately 30 days after your final return visit.

     

    Screenings begin: July 19th 2017

    Anticipated start date for Study 1710:  25 July 2017            

     

    Compensation for participation time: Up to $3725.00 if all clinic visits are completed.

                           

    For information regarding this study contact Kevin @: 651-724-5046 or kfitzgerald@prismresearchinc.com

     

  • Study 1708: Male and Female Participants with Migraine

    Research Purpose: Study 1708 is designed to evaluate the cognitive effects in participants receiving topiramate for prophylactic treatment of migraine comparing immediate release versus extended release formulations. Participants will receive dosings of both FDA approved formulations of topiramate.

     The following will be evaluated:

    • The effect of multiple doses of topiramate (immediate release and extended release) on cognition in participants with migraine.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are not pregnant, considering becoming pregnant, breast feeding or lactating are allowed to participate.  Women using acceptable forms of birth control are allowed to participate.

    Age

    18-65 years

    Body Mass Index (BMI)

    There is no body mass index requirement for this study.

    Weight

    There is no weight requirement for this study.

    Drug Testing

    Must test negative for drugs of abuse. 

    Health History

    History of episodic migraine with or without aura for at least 6 months prior to the screening visit and a frequency of 3 or more headache attacks per month during the past 3 months.

    Right hand dominant.

    On a stable dose for 3 months of a selective serotonin reuptake inhibitor for depression and/or anxiety.

    Special Requirements

    • Must be able and willing to take oral doses of the study medication at home.
    • Must have a working phone number during the entire study.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 8 weeks.

    Inpatient Stay

    • Participants will admit to Prism Clinical Research 3 times
    • The inpatient stay is approximately 1 day one time (1 overnight) and 2 days two times  (2 overnights)

    Outpatient Visits

    • There are 3 outpatient visits during the study.
    • The outpatient visits are approximately 2 hours long. 

     

    Compensation for participation time:   Up to $­­­­­­­­­­­­­­1,660.00

    First screen: 8/28

    First Admit; 9/11

    For information regarding this study contact Kevin at 651-724-5046

  • Study 1714: Healthy Males and Females

    Study 1714 Healthy Female and Male Participants

     

    Research Purpose: To evaluate how one drug interacts with an investigational drug being developed for the treatment of high cholesterol.

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate.

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women using an acceptable method of birth control are allowed to participate.

    Age

    18-60 years of age

    Weight/Body Mass Index (BMI)

    Minimum weight of 50 kg/110 lbs.

    BMI between 18-35 kg/m²

    Tobacco/Nicotine Use

    Subject must be a non-smoker and must have not used tobacco/nicotine containing products including electronic cigarettes within 3 months prior to entering the study.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

    Medications

    No use of any prescription or nonprescription drugs, vitamins, herbal remedies, or dietary supplements within 14 days of entering the study.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 7 weeks.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 2 times.
    • The first in clinic stay will last approximately 4 days (3 overnights).
    • The second in clinic stay will last approximately 4 days (3 overnights).

    Return Clinic Visits

    • There are 12 morning return clinic visits.

     

    Compensation for participation time: Up to $2520.00

     

    For information regarding this study contact Lindsay at: 651-368-3360 lindsayd@prismresearchinc.com or Dayna 651-724-5047 or daynas@prismresearchinc.com

     

  • Study 1718 Healthy Female and Male Participants

    Research Purpose: To evaluate how one drug interacts with an investigational drug being developed for the treatment of certain types of cancers.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate and must use acceptable birth control.

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women using an acceptable method of birth control are allowed to participate.

    Age

    18-55 years of age

    Weight/Body Mass Index (BMI)

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    Subjects must not have used tobacco or tobacco containing products, more frequently than 5 cigarettes per week within 2 months prior to screening or anytime within the week before screening and throughout the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

    Medications

    No use of any prescription or nonprescription drugs, vitamins, herbal remedies, or dietary supplements within at least 14 days of entering the study.

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 7-9 weeks.

    Cohort 1

    Clinic Stay

    • Participants will admit to Prism Clinical Research 2 times.
    • The first in clinic stay will last approximately 3 days (2 overnights).
    • The second in clinic stay will last approximately 11 days (10 overnights).

    Return Clinic Visits

    • There are 7 morning return clinic visits.

    Cohort 2

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in clinic stay will last approximately 9 days (8 overnights).

    Return Clinic Visits

    • There is 1 morning return clinic visit.

    Compensation for participation time:

    Cohort 1 Up to $3675.00

    Cohort 2 Up to $ 2150.00

    For information regarding this study contact Lindsay at: 651-368-3360 lindsayd@prismresearchinc.com or Dayna 651-724-5047 or daynas@prismresearchinc.com

  • Upcoming Studies

     

     

     Prism has a variety of upcoming studies to participate in: 

    • 1711: Vaccine Study (November 2017)
    • 1719: Hepatic Study
    • 1620 Part 3: Volunteers with Atopic Dermatitis
    • Studies for volunteers with Overactive Bladder
    • Studies for healthy males and females

     

    To be put on the call list and receive more information, when available, please contact Dayna at daynas@prismresearchinc.com or Lindsay at lindsayd@prismresearchinc.com.

Hotels

Conveniently located near Prism Clinical Research, you will find...

 

Commons Hotel Minneapolis

Select the link above for Prism/UEL Promotional rate. You may contact by phone, mention your dates of stay and request the University Enterprise Laboratory Rate.

Minneapolis

615 Washington Ave SE

Minneapolis, MN 55414

612-379-8888

 

Courtyard by Marriott

Select the link above for Prism's Promotional rate or call the number below and identify yourself as a customer of Prism Research when making your reservation

Roseville

2905 Centre Pointe Drive

Roseville, MN 55113

651-736-8000

 

Residence Inn by Marriott

Select the link above for Prism's Promotional rate or call the number below and identify yourself as a customer of Prism Research when making your reservation. (Breakfast included)

Roseville

2985 Centre Pointe Drive

Roseville, MN 55113

651-636-0680

 

 

Fairfield Inn and Suites(Marriott)

Roseville

3045 Centre Pointe Drive North

Roseville, MN 55113

651-636 7869

 

Downtown Minneapolis (3 miles)

Minneapolis Marriott City Center

30 South 7th Street

Minneapolis, MN 55402

612-349-4000

 

Downtown St. Paul (4 miles)

The St. Paul Hotel

350 Market Street

St. Paul, MN 55102

800-292-9292

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel